Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CGNT +3.3%, ASX +2.3% (March revs), SAND +1.7%, STLA +1.7% (Q1 update)
Other news:
- ACRV +62.8% (announces $130 million private placement financing)
- OPFI +7% (announces $0.12 per share special dividend, $20 million share repurchase program)
- ALKS +6.1% (Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia)
- OMGA +5.8% (Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control)
- SYRS +5.8% (receives fast track designation from the FDA for tamibarotene for the treatment of newly diagnosed unfit AML with RARA gene overexpression)
- CDE +5.1% (provides update on mine)
- NUVL +5% (presents new preclinical data)
- HL +2.8% (reports Q1 production)
- RKLB +2.1% (U.S. Space Force awards Rocket Lab launch contract for Space Test Program-S30)
- BE +1.8% (to receive up to $75 mln in federal tax credits for Fremont plant)
- GOGO +1.8% (granted regulatory approval for the Gogo Galileo HDX and FDX antenna terminals for business aircraft by the Federal Communications Commission)
- BKD +1.2% (reports March occupancy)
- AL +1.1% (announced an update on aircraft investments, sales, and significant financing activities occurring in the first quarter of 2024)
- AMPY +1% (files for $250 mln mixed securities shelf offering)
- REPX +1% (10% holder,bought 75000 shares worth ~$2.025 mln)